Patient advocacy groups are just starting to realize their enormous potential to help advance treatment of cancer and rare diseases by supporting development of new drugs.
Download our new white paper, The Powerful and Evolving Role of Patient Advocacy Groups in Clinical Research, and learn how advocates are finding new ways to influence study design, recruit patients, and even directly finance clinical trials.
Advocates are giving this underserved community a unified voice.
What does it mean for our industry? Find out!